XTL Biopharmaceuticals Ltd (H2K2) — Net Asset Quality Index
XTL Biopharmaceuticals Ltd (H2K2) has a Net Asset Quality Index of 63.6% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €8.55 Million minus total liabilities of €3.12 Million yields net assets of €5.43 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read H2K2 current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
XTL Biopharmaceuticals Ltd Net Asset Quality Index Over Time (2016–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of December 2024, the index stands at 63.6%, representing net assets of €5.43 Million against total assets of €8.55 Million EUR. For live market cap and overall valuation, see how much is XTL Biopharmaceuticals Ltd worth.
Annual Net Asset Quality Index for XTL Biopharmaceuticals Ltd (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for XTL Biopharmaceuticals Ltd from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check XTL Biopharmaceuticals Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 63.6% | €5.43 Million | €8.55 Million | €3.12 Million | ▼ -27.9 pp |
| 2023 | 91.5% | €2.22 Million | €2.43 Million | €206.00K | ▼ -4.0 pp |
| 2022 | 95.5% | €4.00 Million | €4.19 Million | €187.00K | ▲ +14.9 pp |
| 2021 | 80.6% | €5.33 Million | €6.62 Million | €1.28 Million | ▼ -15.5 pp |
| 2020 | 96.1% | €6.25 Million | €6.50 Million | €254.00K | ▼ -0.7 pp |
| 2019 | 96.8% | €6.98 Million | €7.21 Million | €232.00K | ▼ -0.3 pp |
| 2018 | 97.0% | €8.32 Million | €8.57 Million | €253.00K | ▲ +42.1 pp |
| 2017 | 54.9% | €3.62 Million | €6.59 Million | €2.97 Million | ▼ -34.1 pp |
| 2016 | 89.1% | €2.69 Million | €3.02 Million | €330.00K | — |